期刊文献+

Toll样受体9与感染相关上消化道肿瘤研究进展 被引量:1

Research Progress of Toll-like Receptor 9 and Infection-related Upper Gastrointestinal Tumors
下载PDF
导出
摘要 Toll样受体9(Toll-like receptor 9,TLR9)是免疫系统中的重要受体,可以介导固有免疫及适应性免疫,且在其中具有桥梁作用,近年来TLR9在肿瘤免疫中的研究逐渐深入,发现其在食管癌、胃癌等多种感染相关上消化道肿瘤的发生发展中具有重要的作用。本文对近年相关研究进行综述,旨在探讨TLR9在上消化道肿瘤中未来的研究及临床价值。 TLR9 is an important receptor in the immune system,which can mediate innate immunity and adaptive immunity,and plays a bridge role in it.In recent years.TLR9 has been intensively studied in tumor immunity,and found that it plays an important role in the occurrence and development of various infection-related upper gastrointestinal tumors such as esophageal cancer and gastric cancer.This article reviews the related research in recent years to explore the future research and clinical value of TLR9 in upper gastrointestinal tumors.
作者 张志博 ZHANG Zhi-bo(First Affiliated Hospital,and College of Clinical Medicine of Henan University of Science and Technology,Luoyang,China,471003)
出处 《食管疾病》 2022年第3期188-192,共5页 Journal of Esophageal Diseases
关键词 TOLL样受体9 感染相关肿瘤 食管癌 胃癌 炎症 Toll-like receptor 9 infection-related tumors esophageal cancer gastric cancer inflammation
  • 相关文献

参考文献5

二级参考文献42

  • 1王培桦,沈洪兵,陈峰,赵金扣.叉生分析在基因-环境交互作用研究中的应用与意义[J].中华流行病学杂志,2005,26(1):54-57. 被引量:30
  • 2张国红,苏敏,田东萍.慢性炎症介导的基底膜改变在食管上皮癌变中的作用[J].癌症,2005,24(9):1071-1075. 被引量:7
  • 3Chang X Han J.Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors[J].中国生物学文摘,2006,20(5):5-5. 被引量:19
  • 4Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66. 被引量:1
  • 5Hawes RH, Xiong Q, Waxman I, Chang KJ, Evans DB, Abbruzzese JL. A multispecialty approach to the diagnosis and management of pancreatic cancer. Am J Gastroenterol 2000; 95:17-31. 被引量:1
  • 6Real FX, Cibrian-Uhalte E, Martinelli P. Pancreatic cancer development and progression: remodeling the model. Gastroenterology 2008; 135:724-728. 被引量:1
  • 7Tanase CP, Dima S, Mihai M, Raducan E, Nicolescu MI, Albulescu L, Voiculescu B, Dumitrascu T, Cruceru LM, Leabu M, Popescu I, Hinescu ME. Caveolin-1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma. J Mol Histo12009; 40:23-29. 被引量:1
  • 8Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P, Dervenis C, Fernandez-Cruz L, Lacaine F, Pap A, Spooner D, Kerr DJ, Friess H, Bflchler MW, Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001; 358:1576-1585. 被引量:1
  • 9Jungert K, Buck A, von Wichert G, Adler G, Konig A, Buchholz M, Gress TM, Ellenrieder V. Spl is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells. Cancer Res 2007; 67:1563-1570. 被引量:1
  • 10Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801. 被引量:1

共引文献52

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部